Commonwealth Equity Services’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-27,091
| Closed | -$4.8M | – | 3048 |
|
|
2020
Q1 | $4.8M | Sell |
27,091
-1,682
| -6% | -$317K | 0.02% | 569 |
|
|
2019
Q4 | $5.5M | Sell |
28,773
-216
| -0.7% | -$39K | 0.02% | 595 |
|
|
2019
Q3 | $4.88M | Sell |
28,989
-3,518
| -11% | -$573K | 0.02% | 601 |
|
|
2019
Q2 | $5.44M | Sell |
32,507
-13,293
| -29% | -$1.84M | 0.02% | 540 |
|
|
2019
Q1 | $6.71M | Buy |
45,800
+403
| +0.9% | +$58.4K | 0.03% | 475 |
|
|
2018
Q4 | $6.07M | Sell |
45,397
-5,192
| -10% | -$851K | 0.03% | 450 |
|
|
2018
Q3 | $9.64M | Sell |
50,589
-4,287
| -8% | -$788K | 0.05% | 358 |
|
|
2018
Q2 | $9.15M | Buy |
54,876
+5,572
| +11% | +$895K | 0.05% | 338 |
|
|
2018
Q1 | $8.3M | Sell |
49,304
-208
| -0.4% | -$34.9K | 0.05% | 342 |
|
|
2017
Q4 | $8.1M | Buy |
49,512
+3,953
| +9% | +$709K | 0.04% | 341 |
|
|
2017
Q3 | $9.34M | Buy |
45,559
+2,948
| +7% | +$686K | 0.06% | 289 |
|
|
2017
Q2 | $10.4M | Buy |
42,611
+3,729
| +10% | +$876K | 0.07% | 261 |
|
|
2017
Q1 | $9.29M | Sell |
38,882
-652
| -2% | -$152K | 0.06% | 275 |
|
|
2016
Q4 | $8.3M | Buy |
39,534
+2,222
| +6% | +$460K | 0.06% | 282 |
|
|
2016
Q3 | $8.59M | Buy |
37,312
+6,027
| +19% | +$1.47M | 0.07% | 257 |
|
|
2016
Q2 | $7.23M | Buy |
31,285
+4,198
| +15% | +$968K | 0.06% | 280 |
|
|
2016
Q1 | $7.26M | Buy |
27,087
+1,405
| +5% | +$402K | 0.06% | 274 |
|
|
2015
Q4 | $8.03M | Sell |
25,682
-3,033
| -11% | -$903K | 0.08% | 241 |
|
|
2015
Q3 | $7.8M | Sell |
28,715
-2,225
| -7% | -$683K | 0.08% | 225 |
|
|
2015
Q2 | $9.39M | Buy |
30,940
+1,544
| +5% | +$461K | 0.09% | 213 |
|
|
2015
Q1 | $8.75M | Buy |
29,396
+363
| +1% | +$103K | 0.09% | 214 |
|
|
2014
Q4 | $7.47M | Buy |
29,033
+9,287
| +47% | +$2.32M | 0.08% | 226 |
|
|
2014
Q3 | $4.76M | Buy |
19,746
+9,570
| +94% | +$2.14M | 0.06% | 291 |
|
|
2014
Q2 | $2.27M | Buy |
10,176
+378
| +4% | +$78.3K | 0.03% | 514 |
|
|
2014
Q1 | $2.02M | Sell |
9,798
-7,622
| -44% | -$1.51M | 0.03% | 517 |
|
|
2013
Q4 | $2.93M | Buy |
17,420
+13,380
| +331% | +$2.09M | 0.04% | 359 |
|
|
2013
Q3 | $582K | Sell |
4,040
-52
| -1% | -$6.93K | 0.01% | 1016 |
|
|
2013
Q2 | $516K | Buy |
+4,092
| New | +$463K | 0.01% | 1008 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Commonwealth Equity Services's AGN Position: Q2 2020 in Review
Commonwealth Equity Services sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 27,091 shares — an estimated $4.8M sold.
Commonwealth Equity Services first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $10.4M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Commonwealth Equity Services reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Commonwealth Equity Services sold 27,091 Allergan plc shares in Q2 2020, an estimated $4.8M.
- Commonwealth Equity Services first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Commonwealth Equity Services's Allergan plc position peaked at $10.4M in Q2 2017.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Commonwealth Equity Services's 13F filing for Q2 2020, filed 12 Aug 2020.